Please login to the form below

Not currently logged in
Email:
Password:

Former Ketchum head joins Luther Pendragon

Avril Lee becomes director at the corporate communications consultancy
 

Avril LeeLuther Pendragon has named Avril Lee – former CEO of Ketchum – as director of the communications consultancy.

Lee joins Luther Pendragon after a decade at Ketchum, initially running the healthcare team in London and then Europe, before being appointed CEO for the UK in 2011.

Before joining Ketchum, Lee was deputy MD and a board director at Hill & Knowlton. She is a member of council at the Public Relations Consultants Association (PRCA) and a spokesperson for the Chartered Institute of Public Relations' (CIPR) diversity working group.

Luther Pendragon managing director Simon Whale said he was delighted to have Lee join.

"She is one of the very best in communications, she has a fantastic track record and she brings a wealth of management experience. She is perfectly suited to our integrated, intelligent approach to communications and our broad client base,” he said.

Lee added: "Luther Pendragon is exactly what I was looking for – its plans for growth match my own ambitions and I'm really looking forward to contributing to its continued success."

Whale and Lee will co-lead on healthcare, although she will also work on other client sectors. Luther Pendragon's current healthcare clients include pharmaceutical and other commercial healthcare companies, trade associations, professional bodies and healthcare regulators.


31st October 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics